Filter
2145
Filtered Results: 2145
Text search:
infect
drug
use
Featured
Recommendations
218
New Publications
476
Language
Document type
No document type
1226
Studies & Reports
358
Guidelines
327
Manuals
88
Strategic & Response Plan
55
Fact sheets
39
Training Material
28
Infographics
9
Situation Updates
8
Brochures
4
Resource Platforms
3
Countries / Regions
India
88
Global
55
Kenya
54
South Africa
53
Western and Central Europe
49
Tanzania
46
Nepal
44
Ukraine
37
Latin America and the Carribbean
32
Eastern Europe
30
Ethiopia
29
Nigeria
28
Russia
27
Myanmar / Burma
27
Asia
26
Uganda
26
Africa
24
Zambia
24
Brazil
23
Sierra Leone
22
Malawi
19
Liberia
19
Ghana
18
Namibia
18
Bangladesh
17
Philippines
16
Germany
13
South–East Asia Region
13
Rwanda
12
Mozambique
12
Colombia
10
Albania
9
Senegal
9
Indonesia
9
Lesotho
8
Cambodia
8
Tajikistan
7
Burkina Faso
7
Congo, Democratic Republic of
7
Georgia
7
Zimbabwe
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Botswana
6
Cameroon
5
Venezuela
5
East and Southern Africa
5
Argentina
5
Moldova
5
South Sudan
5
Eswatini/ Swaziland
5
Pakistan
5
North Macedonia
4
Thailand
4
Syria
4
Estonia
4
Peru
4
Benin
3
China
3
USA
3
Haiti
3
Guinea-Bissau
3
Paraguay
3
North America
3
Bolivia
3
Vietnam
3
Yemen
3
Mali
3
Angola
3
Mexico
2
Serbia
2
Turkey
2
Laos
2
Guinea
2
Jordan
2
Uruguay
2
France
2
Spain
2
Papua New Guinea
2
Sri Lanka
2
Sudan
2
Honduras
2
Ecuador
2
Switzerland
1
Timor Leste/ East Timor
1
El Salvador
1
Gambia
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Afghanistan
1
Western Pacific Region
1
Jamaica
1
Belgium
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Egypt
1
Romania
1
Poland
1
Chad
1
Libya
1
Bhutan
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
641
Clinical Guidelines
231
Public Health
71
Women & Child Health
52
Key Resources
35
Pharmacy & Technologies
27
Capacity Building
24
Toolboxes
HIV
498
TB
284
NTDs
139
COVID-19
129
AMR
118
Mental Health
79
Rapid Response
46
Malaria
38
Pharmacy
37
Ebola & Marburg
35
Refugee
33
Caregiver
27
Planetary Health
27
NCDs
16
Health Financing Toolbox
13
Zika
12
Polio
12
Global Health Education
11
Conflict
10
Cholera
7
Specific Hazards
5
Natural Hazards
4
Disability
3
Social Ethics
2
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
Community-based health care, including outreach and campaigns,in the context of the COVID-19 pandemic
recommended
The COVID-19 pandemic is challenging health systems across the world. Rapidly increasing demand for care of people with COVID-19 is compounded by fear, misinformation and limitations on the movement of people and supplies that disrupt the delivery of frontline health care for all people...
This g...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and control for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infr...
COVID-19 outbreak is associated with the generation of many types of infectious wastes, including infected masks, gloves and other protective equipment, together with a higher volume of general waste of the same nature.
PLoS Negl Trop Dis 13(10): e0007694. In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Developmen...
The Lancet Global Health January 24, 2022
Interferon-γ Assays - Description and Assessment of a New Tool in the Diagnosis of Tuberculosis.
Haür B et al. Interferon-γ-Tests in der ...Pneumologie 2006; 60: 29-44
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ...
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepared, according to the first annual report from the Global Preparedness Monitoring Board. The WHO and the World Bank convened the independent group after ...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
Schistosoma haematobium is a parasitic digenetic trematode responsible for schistosomiasis (also known as bilharzia). The disease is caused by penetration of the skin by the parasite, spread by intermediate host molluscs in stagnant waters, and can be treated by administration of praziquantel. Schis...
The skin of a patient is the first and most visible structure of the body that any health-care worker encounters during the course of an examination. To the patient, it is also highly visible, and any disease that affects it is noticeable and will have an impact on personal and social well-being. Th...
WHO practical guidelines. 2nd edition
